Skip to content

Arcutis Biotherapeutics, Inc. ARQT Prepaid & Other Current

Prepaid & Other Current at other companies

Amgen logo
AmgenAMGN
$4.11B+26.2%
Incyte logo
IncyteINCY
$301.31M+42.4%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.53M-61.2%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$26.5M+48.9%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$5.73M+49.4%
LQD
Liquidia CorporationLQDA
$7.61M+56.8%

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Gross profit$95.6M+67.7%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.29B+57.5%

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s prepaid & other current?
Arcutis Biotherapeutics, Inc. (ARQT) reported prepaid & other current of $31.98M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s prepaid & other current changed year-over-year?
Arcutis Biotherapeutics, Inc.'s prepaid & other current increased by 39.4% year-over-year, from $22.94M to $31.98M.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s prepaid & other current?
Over 4 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s prepaid & other current has grown at a 7.0% compound annual growth rate (CAGR), from $63.28M to $82.96M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.